Skip to main content

RHUMBLINE ADVISERS

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in ZVRA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$634,421
+$22,597 QoQ
Shares Held
68,071
-0.3% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 21.69058776865332.ToString("F0")% Shared 0.ToString("F0")% None 78.30941223134668.ToString("F0")%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. ZVRA ranks #141 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZVRA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $634,421 68,071
2025-12-31 $611,824 68,284
2025-09-30 $736,920 77,489
2025-06-30 $733,177 83,221
2025-03-31 $558,641 74,585
2024-12-31 $567,562 68,053
2024-09-30 $398,911 57,480
2024-06-30 $278,682 56,874
2024-03-31 $279,879 48,255
2023-12-31 $309,094 47,190
2023-09-30 $220,375 45,721
2023-06-30 $220,131 43,163
2022-03-31 $162,876 32,381
2021-12-31 $289,442 33,231
2021-09-30 $305,324 32,725
2021-06-30 $408,086 31,832